1-(5-isoquinolinesulfonyl)-2-methylpiperazine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gojo, A; Ishizawa, S; Kanazawa, Y; Kurata, H; Tajima, N; Taniguchi, K; Utsunomiya, K; Yokota, T1

Other Studies

1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
    European journal of pharmacology, 2007, Jul-30, Volume: 568, Issue:1-3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Animals; Blood Glucose; Blood Pressure; Cholesterol; Connective Tissue Growth Factor; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immediate-Early Proteins; Indoles; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Kidney Cortex; Male; NADPH Oxidase 4; NADPH Oxidases; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; RNA, Messenger; Streptozocin; Transforming Growth Factor beta

2007